Check-Cap (CHEK) Reports Q1 Loss of $0.53/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. AAPL
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Check-Cap (CHEK) Reports Q1 Loss of $0.53/Share

Check-Cap Reports First Quarter 2015 Financial Results and Provides Corporate Update

June 4, 2015 9:15 AM EDT

ISFIYA, Israel, June 4, 2015 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:  CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced financial results for the first quarter, ended March 31, 2015.

"In recent months, Check-Cap has made significant progress advancing our corporate and clinical objectives," said Guy Neev, CEO of Check-Cap. "Following our IPO in February, we received a critical Notice of Allowance from the U.S. Patent and Trademark Office, further strengthening our global intellectual property position. In... More